#YonhapInfomax #KOSPI #KOSDAQ #BiotechStocks #ForeignInvestors #RecordHighs #Economics #FinancialMarkets #Banking #Securities #Bonds #StockMarket
https://en.infomaxai.com/news/articleView.html?idxno=101767
Asian stock markets rallied as weaker US jobs data fueled expectations of a Federal Reserve rate cut, with major indices in Japan, China, Hong Kong, and Taiwan closing higher. Japanese government bond yields fell, the yuan strengthened, and biotech shares led gains in Hong Kong.
🚨 Anthem Biosciences makes a stellar market debut!
📈 Listed at ₹723 — a 27% premium over the IPO price of ₹570.
💰 IPO subscribed 63.86 times!
With a 30% YoY revenue growth and global CRDMO dominance, is Anthem India’s next biotech star?
📊 FY25 Net Profit: ₹451 Cr | EBITDA Margin: 36.8%
🔗 Read the full analysis to know if you should invest.
#AnthemBiosciences #StockMarketIndia #IPOListing #BiotechStocks #CRDMO #PharmaInvesting #AnthemSharePrice https://news24media.org/anthem-biosciences-share-price/
Anthem Biosciences share Price News Today (July 21, 2025): Anthem Biosciences made an impressive entry into the Indian stock market on Monday, debuting at ₹723 per share on the BSE — a solid 27% premium over its IPO issue price of ₹570.
$HOFV
✅ Float under 4M
✅ Extremely oversold (Stoch under 10)
✅ Bouncing from the same zone it exploded from last time — over 100% move
✅ This stock loves to pop without warning
✅ Holding above strong support… one clean breakout and it’s game on
Smart money positions early. Watch closely.